Update
$Moleculin Biotech (MBRX.US)$ Reuters· just
Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of Stat3 Inhibitor in Combination With Radiation for the Treatment of Glioblastoma
Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of Stat3 Inhibitor in Combination With Radiation for the Treatment of Glioblastoma
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
